/주식/MIRA
MIRA

MIRA

USD

MIRA Pharmaceuticals Inc. Common Stock

$1.570-0.120 (-7.101%)

실시간 가격

Healthcare
Drug Manufacturers - General
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$1.690

고가

$1.725

저가

$1.560

거래량

0.04M

기업 기본 정보

시가총액

32.7M

산업

Drug Manufacturers - General

국가

United States

거래 통계

평균 거래량

3.18M

거래소

NCM

통화

USD

52주 범위

저가 $0.73현재가 $1.570고가 $2.45

관련 뉴스

AccessWire

MIRA Pharmaceuticals Initiates Multiple Ascending Dose (MAD) Phase 1 Study of Oral Ketamir-2 and Selects Chemotherapy-Induced Neuropathic Pain as Lead Phase 2a Indication

Advancing toward Phase 2a clinical evaluation in chemotherapy-related pain, a condition with no approved treatments and potential for FDA Fast Track consideration MIAMI, FLORIDA / ACCESS Newswire / October 24, 2025 /

더 보기
MIRA Pharmaceuticals Initiates Multiple Ascending Dose (MAD) Phase 1 Study of Oral Ketamir-2 and Selects Chemotherapy-Induced Neuropathic Pain as Lead Phase 2a Indication